Nachrichten zur Hims & Hers Health Aktie

Hims & Hers health CFO sells shares worth nearly $197k…

There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition…

Hims & Hers Health, Inc. HIMS shares rallied 10.1% in the last trading session to close at $19.44. This move…

Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings…

As a player in the growing telehealth sector, Hims Hers Health ($HIMS) has grown significantly, driving its stock up…

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the target of some unusual options trading activity on…

Hims & Hers Health (NYSE:HIMS) Shares Gap Up - Still a Buy?…

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise…

Hims & Hers wird am 9. Oktober 2024 in den S&P SmallCap 600-Index aufgenommen, was für das Unternehmen ein wichtiger…

HIms & Hers shares rise premarket on upcoming inclusion in S&P SmallCap 600…

Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS…

…

Hims & Hers Health (HIMS) is expected to join the S&P SmallCap 600 Index on Wedensday, replacing Vector Group (VIGR),…

Hims Hers Health (HIMS) will replace Vector Group Ltd (VGR) in the SP SmallCap 600 effective prior to the…

The Food and Drug Administration last night said it determined the shortage of tirzepatide injection, a glucagon-like peptide medication, has…

Citi keeps a Neutral rating on Hims Hers (HIMS) after the FDA officially removed Eli Lilly’s (LLY) Tirzepatide from…

NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in…

NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in…

Hims & Hers Health to join S&P SmallCap 600, replacing Vector Group. Learn how this index change impacts the Health…

Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to…

Mihir Gandhi and Dr. Jessica Yu join Lady T to discuss how Hims & Hers provides weight loss treatment to…

Bearish investors decided to classify Hims & Hers Health (HIMS) as an obesity drug supplier. HIMS stock lost 9.6% on…

Over 100 million Americans face weight-related challenges, but new GLP-1 medications offer hope. Barriers like high costs and shortages prevent…

Justin spoke with Mihir Gandhi and Dr. Jessica Yu who are two medical professionals representing Hims & Hers. The focus…

Hims & Hers may not be hurt by GLP-1 news the way investors think.…